Medical Care Technologies Inc. Introduces AI-Powered Facial Analysis for Diabetic Retinopathy Detection

MESA, ARIZONA / ACCESS Newswire / September 26, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) unveiled its AI Facial Health Risk Estimator for early detection of diabetic retinopathy, a leading cause of preventable blindness worldwide.

The system analyzes subtle retinal cues captured from standard facial imaging, identifying microaneurysms, hemorrhages, and vascular leakage, allowing for non-invasive, accessible early screening.

"Diabetic retinopathy often goes undiagnosed until vision loss occurs," said Marshall Perkins, CEO of MDCE. "Our AI technology allows earlier detection, broader screening access, and better patient outcomes."

Company Websites: www.medicalcaretechnologies.com | www.mdcestock.com

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK: MDCE) is at the forefront of AI-driven preventive healthcare, providing early detection tools across systemic, ocular, and dermatological conditions.

Safe Harbor Statement:
Forward-looking statements are included in this release. Risks and uncertainties may cause actual results to differ materially.

Contact:

Investor Relations
Medical Care Technologies Inc.
[e-mail]
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire


The Medical Care Technologies Stock at the time of publication of the news with a raise of +50,00 % to 0,000USD on Nasdaq OTC stock exchange (26. September 2025, 02:10 Uhr).